RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Maia Biotechnology Stock

Maia Biotechnology Debt 2024

Maia Biotechnology Debt

-7.15 USD

Ticker

MAIA

ISIN

US5526411021

In 2024, Maia Biotechnology's total debt was -7.15 USD, a -34.7% change from the -10.95 USD total debt recorded in the previous year.

Maia Biotechnology Aktienanalyse

What does Maia Biotechnology do?

Maia Biotechnology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Maia Biotechnology's Debt Structure

Maia Biotechnology's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Maia Biotechnology's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Maia Biotechnology’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Maia Biotechnology’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Maia Biotechnology stock

What is the debt of Maia Biotechnology this year?

Maia Biotechnology has a debt level of -7.15 USD this year.

What was the debt of Maia Biotechnology compared to the previous year?

The debt of Maia Biotechnology has increased by -34.7% compared to the previous year dropped.

What are the consequences of high debt for investors in Maia Biotechnology?

High debt can pose a risk for investors of Maia Biotechnology, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Maia Biotechnology?

Low debt means that Maia Biotechnology has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Maia Biotechnology affect the company?

An increase in debt of Maia Biotechnology can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Maia Biotechnology affect the company?

A reduction in debt of Maia Biotechnology can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Maia Biotechnology?

Some factors that can influence the debt of Maia Biotechnology include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Maia Biotechnology so important for investors?

The debts of Maia Biotechnology are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Maia Biotechnology take to change the debt?

To change the debt, Maia Biotechnology can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Maia Biotechnology pay?

Over the past 12 months, Maia Biotechnology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Maia Biotechnology is expected to pay a dividend of 0 USD.

What is the dividend yield of Maia Biotechnology?

The current dividend yield of Maia Biotechnology is .

When does Maia Biotechnology pay dividends?

Maia Biotechnology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Maia Biotechnology?

Maia Biotechnology paid dividends every year for the past 0 years.

What is the dividend of Maia Biotechnology?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Maia Biotechnology located?

Maia Biotechnology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Maia Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Maia Biotechnology from 11/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/2/2024.

When did Maia Biotechnology pay the last dividend?

The last dividend was paid out on 11/2/2024.

What was the dividend of Maia Biotechnology in the year 2023?

In the year 2023, Maia Biotechnology distributed 0 USD as dividends.

In which currency does Maia Biotechnology pay out the dividend?

The dividends of Maia Biotechnology are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Maia Biotechnology

Our stock analysis for Maia Biotechnology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Maia Biotechnology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.